 |
antibody drug conjugate targeting dipeptidase 3 (DPEP3) |
|---|---|
| Trade Name | |
| Orphan Indication | DPEP3-positive ovarian, fallopian tube, and primary peritoneal cancers |
| USA Market Approval | USA |
| USA Designation Date | 2018-01-08 00:00:00 |
| Sponsor | AbbVie Stemcentrx, LLC;1 North Waukegan Road;Chicago, Illinois, 60064 |
